Peripheral Nerve Abnormalities in Adrenomyeloneuropathy: a Clinical and Electrodiagnostic Study
Affiliations
Adrenomyeloneuropathy (AMN) is one of the most frequent phenotypes of X-linked adrenoleukodystrophy. Whether the polyneuropathy in AMN results from primary demyelination or axonal degeneration is uncertain. We examined 23 patients (18 men with AMN and five female carrier with AMN symptomatology), performed electroneurography and EMG, and compared our results with standardized electrodiagnostic criteria for primary demyelination. Both clinically and electrodiagnostically, the lower extremities were most frequently and most severely affected. A longer duration of symptoms was related to more severe pyramidal dysfunction (p < 0.004) and spasticity (p < 0.04), and to a more severe impairment of vibration sense (p < 0.05). There were on correlations between the different electrophysiologic studies and the duration of neurologic symptoms. Only two AMN patients (9%) fulfilled the electrodiagnostic criteria for primary demyelination. However, both had abnormally low compound muscle action potentials, which may have been a reflection of primary axonal degeneration. Six other patients (26%) partially fulfilled the criteria for primary demyelination, of whom five also manifested low compound muscle action potentials. In 15 patients (65%), we found polyneuropathy with predominantly axonal, sensorimotor features. We conclude that the neuropathy in AMN patients is due to primary axonal degeneration.
Zhang L, Yu Y, Liu T, Li C, Tan L, Wen S Orphanet J Rare Dis. 2025; 20(1):20.
PMID: 39806482 PMC: 11727801. DOI: 10.1186/s13023-024-03499-x.
Progression of Spinal Cord Disease in Adult Men With Adrenoleukodystrophy.
Yska H, Voermans M, Kabak E, Engelen M J Inherit Metab Dis. 2025; 48(1):e12845.
PMID: 39777696 PMC: 11706703. DOI: 10.1002/jimd.12845.
Kornbluh A, Baldwin A, Fatemi A, Vanderver A, Adang L, Van Haren K Neurol Genet. 2024; 10(5):e200192.
PMID: 39372123 PMC: 11450743. DOI: 10.1212/NXG.0000000000200192.
Yska H, Engelen M, Bugiani M Orphanet J Rare Dis. 2024; 19(1):138.
PMID: 38549180 PMC: 10976706. DOI: 10.1186/s13023-024-03105-0.
Intrathecal administration of mesenchymal stem cells in patients with adrenomyeloneuropathy.
Siwek T, Zwiernik B, Jezierska-Wozniak K, Jezierska K, Mycko M, Selmaj K Front Neurol. 2024; 15:1345503.
PMID: 38370525 PMC: 10869536. DOI: 10.3389/fneur.2024.1345503.